TPG Capital, the private equity platform of TPG, Fort Worth and San Francisco-based private equity alternative asset firm, announced Feb. 10 it has finalized its agreement to acquire Mediware Information Systems Inc from private equity firm Thoma Bravo. Terms of the transaction were not disclosed.
Lenexa, Kansas-based Mediware is a leading supplier of software as a service and other software platforms for health care and human services providers and payers across acute, non-acute, and community-based sites of care.
Primary product categories include non-acute care, human and social services, blood management, and medication management, making the company a strong addition to TPG’s diverse portfolio, which includes a number of companies in the healthcare IT sector, such as Evolent Health and QuintilesIM, according to the news release.
“Through our partnership with TPG, Mediware now has access to substantial expertise and resources, and we are looking forward to building on the progress we’ve made over the past four years,” said Mediware’s President and CEO Thomas Mann.
“We see significant potential with Mediware, given its leading position in a rapidly evolving industry. We are committed to working with the team to capitalize on exciting growth opportunities,” said Jeffrey Rhodes, a partner at TPG
“We look forward to supporting Mediware with investments in both organic and inorganic growth. These investments will help us build the market-leading non-acute care and human services software platform,” said Nehal Raj, Partner at TPG.
Formed in 1980, Mediware provides software solutions to health care providers and has expanded to serve many state and federal agencies.